Evolva in collaboration with Ajinomoto Co
Evolva Holding SA announced that it has entered into a collaboration agreement with Ajinomoto Co. Inc., Japan, for the joint development of novel fermentation production routes for a natural functional ingredient for application in Personal Care.
During the 3½ year collaboration, Ajinomoto Co will fund research and development activities at Evolva, focused initially on building a novel, valuable pathway with Evolva’s fermentation technology and subsequently on improving production yield through the scale-up and manufacturing phases. During the collaboration, 7 full-time scientists at Evolva are expected to work on the program. Evolva will receive an upfront exclusivity and technology access fee as well as monthly research fees. In addition, Evolva will receive milestone payments upon achieving certain goals in terms of yield, productivity and production costs. The total fees and milestone payments to Evolva during the collaboration will amount to more than CHF 10 million. In case of commercialisation, Evolva will receive a royalty as a percentage on product sold.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
